BRISTOL-MYERS SQUIBB COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.96 USD | -0.15% |
|
+1.82% | +0.65% |
| Jan. 17 | Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks | MT |
| Jan. 17 | Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks | MT |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 21 | |||||||||
| 26 | |||||||||
| 22 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 24 | |||||||||
| 18 | |||||||||
| 19 | |||||||||
| 19 | |||||||||
| 22 | |||||||||
| 26 | |||||||||
| 21 | |||||||||
| 26 | |||||||||
| 15 | |||||||||
| 18 | |||||||||
| 18 | |||||||||
| 17 | |||||||||
| 17 | |||||||||
| 16 | |||||||||
| Average | 21 | ||||||||
| Weighted average by Cap. | 22 |
- Stock Market
- Equities
- BMY Stock
- Sector Bristol-Myers Squibb Company
- Sector revisions